World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
61
Citations
13188
World Ranking
3002
National Ranking
68

Overview

Milos Opravil is affiliated with the University of Zurich in Switzerland. Their academic profile is characterized by a presence within the institution, indicating involvement in research and teaching activities at this university.

The available data does not provide details on recent papers, co-authors, publication venues, or specific fields of study. Consequently, no information on particular research topics, subfields, or scientific contributions through publications can be outlined.

There are no records of book publications under their name, nor any documented awards that have been granted to them to date.

This profile therefore focuses primarily on their association within the academic environment of the University of Zurich, without additional details on research output or collaborations.

Best Publications

  • Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients : a prospective cohort study

    Bruno Ledergerber;Matthias Egger;Milos Opravil;Amalio Telenti

  • Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study.

    Jacques Fellay;Catia Marzolini;Emma R. Meaden;David J. Back

  • AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study.

    Bruno Ledergerber;M. Egger;V. Erard;R. Weber

  • CD4 T-Lymphocyte Recovery in Individuals With Advanced HIV-1 Infection Receiving Potent Antiretroviral Therapy for 4 Years: The Swiss HIV Cohort Study

    Gilbert R. Kaufmann;Luc Perrin;Guiseppe Pantaleo;Milos Opravil

  • Primary pulmonary hypertension in HIV infection.

    Rudolf Speich;Rolf Jenni;Milos Opravil;Marlene Pfab

  • Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy.

    Gilbert R. Kaufmann;Hansjakob Furrer;Bruno Ledergerber;Luc Perrin

  • HIV-associated primary pulmonary hypertension. A case control study. Swiss HIV Cohort Study.

    M. Opravil;Marc Pechere;R. Speich;H. I. Joller-Jemelka

  • Discontinuation of primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1-infected adults treated with combination antiretroviral therapy. Swiss HIV Cohort Study.

    Hansjakob Furrer;Matthias Egger;Milos Opravil;Enos Bernasconi

  • Bosentan for the treatment of human immunodeficiency virus-associated pulmonary arterial hypertension.

    Olivier Sitbon;Virginie Gressin;Rudolf Speich;Peter S. Macdonald

  • Hyperlactatemia and Antiretroviral Therapy: The Swiss HIV Cohort Study

    K. Boubaker;Markus Flepp;Philippe Sudre;Hansjakob Furrer

  • Impact of drug resistance mutations on virologic response to salvage therapy. Swiss HIV Cohort Study.

    Patrizio Lorenzi;Milos Opravil;Bernard Hirschel;Jean-Philippe Chave

  • Frequent chronic hepatitis B virus infection in HIV-infected patients positive for antibody to hepatitis B core antigen only. Swiss HIV Cohort Study.

    Hofer M;Joller-Jemelka Hi;Grob Pj;Lüthy R

  • Pulmonary Arterial Hypertension Related to HIV Infection: Improved Hemodynamics and Survival Associated with Antiretroviral Therapy

    Jean-Philippe Zuber;Alexandra Calmy;John M. Evison;Barbara Hasse

  • A controlled study of inhaled pentamidine for primary prevention of Pneumocystis carinii pneumonia.

    Bernard Hirschel;A. Lazzarin;P. Chopard;M. Opravil

  • Updated European recommendations for the clinical use of HIV drug resistance testing

    A. M. Vandamme;A. Sönnerborg;M. Ait-Khaled;J. Albert

  • A Randomized Trial of Simplified Maintenance Therapy with Abacavir, Lamivudine, and Zidovudine in Human Immunodeficiency Virus Infection

    Milos Opravil;Bernard Hirschel;Adriano Lazzarin;Hansjakob Furrer

  • A placebo-controlled trial of didanosine plus stavudine, with and without hydroxyurea, for HIV infection

    Olivier T. Rutschmann;Milos Opravil;Anne Iten;Raffaele Malinverni

  • Abnormalities of body fat distribution in HIV-infected persons treated with antiretroviral drugs: The Swiss HIV Cohort Study.

    Enos Bernasconi;Karim Boubaker;Cornelia Junghans;Markus Flepp

  • Enteric Infections and Diarrhea in Human Immunodeficiency Virus-Infected Persons Prospective Community-Based Cohort Study

    Rainer Weber;Bruno Ledergerber;Reinhard Zbinden;Martin Altwegg

  • Clinical efficacy of early initiation of HAART in patients with asymptomatic HIV infection and CD4 cell count > 350 × 106/l

    Milos Opravil;Bruno Ledergerber;Hansjakob Furrer;Bernard Hirschel

  • CD4 T-Lymphocyte Recovery in Individuals With Advanced HIV-1 Infection Receiving Potent Antiretroviral Therapy for 4 Years

    Gilbert R. Kaufmann;Luc Perrin;Guiseppe Pantaleo;Milos Opravil

Frequent Co-Authors

Rainer Weber
Rainer Weber University of Zurich
Hansjakob Furrer
Hansjakob Furrer University of Bern
Enos Bernasconi
Enos Bernasconi Universita della Svizzera Italiana
Bruno Ledergerber
Bruno Ledergerber University of Zurich
Manuel Battegay
Manuel Battegay University Hospital of Basel
Pietro Vernazza
Pietro Vernazza University of St. Gallen
Bernard Hirschel
Bernard Hirschel University of Geneva
Huldrych F. Günthard
Huldrych F. Günthard University of Zurich
Amalio Telenti
Amalio Telenti VIR Biotechnology (United States)
Marek Fischer
Marek Fischer University of Zurich

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying microbiology opens doors to various healthcare and science-related careers. For those interested in swiftly entering the healthcare industry, exploring fast online medical billing and coding certification programs can provide valuable skills and meaningful employment in administrative roles.

If you're aiming for advanced medical roles, numerous medical degrees online that pay well offer flexible options that could complement a microbiology background, enhancing your expertise and job prospects in fields like healthcare management or medical research.

For public health enthusiasts, enrolling in online MPH programs easy to get into can be an accessible way to boost your qualifications and impact community health, often blending well with microbiology studies.

Additionally, if you are passionate about supporting children’s well-being, learning how much does a child life specialist make and the career requirements can help you decide if this rewarding healthcare path aligns with your skills and interests.

Best Scientists Citing Milos Opravil

Trending Scientists

Recently Published Articles